Exact Mass: 548.2819156
Exact Mass Matches: 548.2819156
Found 500 metabolites which its exact mass value is equals to given mass value 548.2819156
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cymarin
Cymarin is a cardenolide glycoside. Cymarin is a natural product found in Apocynum cannabinum, Adonis amurensis, and other organisms with data available. A cardiotonic cardiac glycoside found in STROPHANTHUS. The aglycone is STROPHANTHIN. C - Cardiovascular system > C01 - Cardiac therapy > C01A - Cardiac glycosides > C01AC - Strophanthus glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D013328 - Strophanthins D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents
Antimycin A
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D000935 - Antifungal Agents
Tamoxifen-N-glucuronide
Tamoxifen-N-glucuronide is a metabolite of tamoxifen. Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen. In other tissues such as the endometrium, it behaves as an agonist, and thus may be characterized as a mixed agonist/antagonist. Tamoxifen is the usual endocrine therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting. (Wikipedia)
MPPa (Methyl pyropheophorbide-a)
Murabutide
Trh-gly-lys
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Murabutida
20-Hydroxyganoderic Acid G
Baccharinoid B 20
[7R(R)]-2-Deoxy-7-deoxo-4,16-dihydroxy-7-(1-hydroxyethyl)verrucarin A
[7R(R)]-7-Deoxo-16-hydroxy-7-(1-hydroxyethyl)verrucarin A
Myristinin A
[2R,7R(S),8R]-7-Deoxo-8-hydroxy-7-(1-hydroxyethyl)verrucarin A
8,9,10,22-tetrahydroxy-7,18-dimethyl-19-(5-oxo-2H-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.03,12.05,10.015,23.018,22]pentacosane-14-carbaldehyde
Deacetyltanghinin
A cardenolide glycoside that is the deacetyl derivative of tanghinin. Isolated from Cerbera manghas, it exhibits cytotoxic activities against oral human epidermoid carcinoma (KB), human breast cancer cell (BC) and human small cells lung cancer.
3,12-O-diacetyl-7-O-(2-methylbutanoyl)-8-O-methylingol
Euphorbia factor L7a
Euphorbia factor L7a, a diterpenoid compound, can be isolated from the seeds of Euphorbia lathyris[1].
(32S,6S)-31-(N,N-dimethyl-L-phenylalanyl)-6-isobutyl-14-methoxy-(32rH,33tH)-2-oxa-5,8-diaza-1(1,4)-benzena-3(3,2)-pyrrolidina-cyclodecaphan-9c-ene-4,7-dione|Nummularin-C|nummularine-C
caseamembrin P|rel-(2S,5R,6S,7R,8S,9S,10R,18S,19R)-2,18-dibutanoyloxy-19-acetoxy-18,19-epoxy-6,7-dihydroxy-cleroda-3,13(16),14-triene
3-O-(2,6-Dideoxy-beta-D-xylo-hexopyranoside)-3,5,11,14-Tetrahydroxy-19-oxocarda-6,20(22)-dienolide
7,12-O-diacetyl-3-O-(2-methylbutanoyl)-8-O-methylingol
3-Angeloyl,8-(2-methylbutanoyl),14,15-di-Ac-(3beta,8beta,9beta)-14,15-Epoxy-4-isocedrene-3,8,9,14,15-pentol
3-(hexopyranosyloxy)-14-hydroxy-19-oxocarda-5,20(22)-dienolide
3beta-alpha-L-Acofriopyranosyloxy-1beta,14-dihydroxy-14beta-carda-4,20(22)-dienolid|3beta-alpha-L-acofriopyranosyloxy-1beta,14-dihydroxy-14beta-carda-4,20(22)-dienolide
10,11-epoxy-1beta-hydroxy-2beta,4alpha,8-triangeloyloxybisabol-7(14)-ene
(3S,5S)-1,7-bis(3,4,5-trimethoxyphenyl)heptane-3,5-diyl diacetate|(3S,5S)-3,5-diacetoxy-1,7-bis(3,4,5-trimethoxyphenyl)heptane
(20S,22R,24S,25R)-3beta-acetylthio-5alpha,24alpha-dihydroxy-6alpha,7alpha-epoxy-1-oxowithan-26,22-olide|dioscorolide B
reevesioside C|strophanthidin-4,6-dideoxy-2-O-methyl-beta-D-allopyranoside
3-(3-formamido-2-hydroxybenzamido)-8-pentyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl 2,3-dimethylbutanoate|antimycin A19
9alpha,10beta-diacetoxy-5alpha-cinnamoyloxy-3,11-cyclotaxa-4(20)-en-13-one
14-Hydroxy-3beta(O3-methyl-beta-D-fucopyranosyloxy)-11-oxo-5beta,14beta-card-20(22)-enolid|14-hydroxy-3beta(O3-methyl-beta-D-fucopyranosyloxy)-11-oxo-5beta,14beta-card-20(22)-enolide
(-)-14-hydroxy-3beta-(3-O-methyl-6-deoxy-alpha-L-glucopyranosyl)-11alpha,12alpha-epoxy-(5beta,14beta,17betaH)-card-20(22)-enolide|Anticancer Cardiac Glycoside PMV70P691-007
rel-(3aR,5aS,6S,7aR,7bS,11R,11aR,12aS,13aR)-11-[(2R,3R,5R,8S)-3,8-dimethyl-7-oxo-1,6-dioxaspiro[4.4]non-2-yl]-tetradecahydro-6,12a-dihydroxy-5,5,11-trimethyl-2H,9H-furo[3,2:2,3]furo[3,4:5,6]azuleno[1,2-b]pyran-2,9-dione|schintrilactone C
3,7-O-diacetyl-12-O-(2-methylbutanoyl)-8-O-methylingol
(3beta,5beta,16beta)-3-[(2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy]-14,16-dihydroxycard-20(22)-enolide 16-formate|16-formate 3beta-digitoxosylgitoxigenin|3beta-(beta-D-ribo-2,6-dideoxy-hexopyranosyloxy)-16beta-formyloxy-14-hydroxy-5beta,14beta-card-20(22)-enolide|3beta-(beta-D-ribo-2,6-Didesoxy-hexopyranosyloxy)-16beta-formyloxy-14-hydroxy-5beta,14beta-card-20(22)-enolid|gitoxigenin 16beta-formate 3beta-digitoxoside
(11S)-6-acetyl-124-methoxy-13-oxa-1,6,10,21-tetraaza-12(1,3),14(1,4)-dibenzena-bicyclo[9.6.6]tricosaphan-15c-ene-17,22-dione|Chaenorhin|Chaenorhine|chaenorrhine|chenorhine|chenorrhine
Animicin A
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.578 D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D000935 - Antifungal Agents relative retention time with respect to 9-anthracene Carboxylic Acid is 1.579 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.582
Antimycin A
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D000935 - Antifungal Agents A nine-membered bis-lactone having methyl substituents at the 2- and 6-positions, an n-hexyl substituent at the 8-position, an acyloxy substituent at the 7-position and an aroylamido substituent at the 3-position. It is produced by Streptomyces bacteria and has found commercial use as a fish poison.
1-[2,4,6-trihydroxy-3-[7-hydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-4-yl]phenyl]dodecan-1-one
C29H40O10_7aH,13aH-Cyclopenta[7,8]phenanthro[2,3-b]pyrano[3,2-e][1,4]dioxin-13a-carboxaldehyde, 1-(2,5-dihydro-5-oxo-3-furanyl)eicosahydro-1,3a,11,11a-tetrahydroxy-9,15a-dimethyl-, (1S,3aS,3bR,6aR,9R,11R,11aS,12aR,13aR,15aS)
C30H44O9_(3beta,5beta,8xi,9xi,17alpha)-3-[(6-Deoxy-3-O-methyl-alpha-L-glucopyranosyl)oxy]-14-hydroxy-19-oxocard-20(22)-enolide
1-[2,4,6-trihydroxy-3-[7-hydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-4-yl]phenyl]dodecan-1-one
Cys Ile Lys Trp
C26H40N6O5S (548.2780750000001)
Cys Ile Trp Lys
C26H40N6O5S (548.2780750000001)
Cys Lys Ile Trp
C26H40N6O5S (548.2780750000001)
Cys Lys Leu Trp
C26H40N6O5S (548.2780750000001)
Cys Lys Trp Ile
C26H40N6O5S (548.2780750000001)
Cys Lys Trp Leu
C26H40N6O5S (548.2780750000001)
Cys Leu Lys Trp
C26H40N6O5S (548.2780750000001)
Cys Leu Trp Lys
C26H40N6O5S (548.2780750000001)
Cys Trp Ile Lys
C26H40N6O5S (548.2780750000001)
Cys Trp Lys Ile
C26H40N6O5S (548.2780750000001)
Cys Trp Lys Leu
C26H40N6O5S (548.2780750000001)
Cys Trp Leu Lys
C26H40N6O5S (548.2780750000001)
Asp Lys Met Arg
C21H40N8O7S (548.2740530000001)
Asp Lys Arg Met
C21H40N8O7S (548.2740530000001)
Asp Lys Thr Trp
Asp Lys Trp Thr
Asp Met Lys Arg
C21H40N8O7S (548.2740530000001)
Asp Met Arg Lys
C21H40N8O7S (548.2740530000001)
Asp Arg Lys Met
C21H40N8O7S (548.2740530000001)
Asp Arg Met Lys
C21H40N8O7S (548.2740530000001)
Asp Thr Lys Trp
Asp Thr Trp Lys
Asp Trp Lys Thr
Asp Trp Thr Lys
Glu Lys Ser Trp
Glu Lys Trp Ser
Glu Ser Lys Trp
Glu Ser Trp Lys
Glu Trp Lys Ser
Glu Trp Ser Lys
Phe Phe His Val
Phe Phe Val His
Phe His Phe Val
Phe His Val Phe
Phe Val Phe His
Phe Val His Phe
His Phe Phe Val
His Phe Val Phe
His His Lys Gln
His His Gln Lys
His Lys His Gln
His Lys Gln His
His Gln His Lys
His Gln Lys His
His Val Phe Phe
Ile Cys Lys Trp
C26H40N6O5S (548.2780750000001)
Ile Cys Trp Lys
C26H40N6O5S (548.2780750000001)
Ile Lys Cys Trp
C26H40N6O5S (548.2780750000001)
Ile Lys Trp Cys
C26H40N6O5S (548.2780750000001)
Ile Trp Cys Lys
C26H40N6O5S (548.2780750000001)
Ile Trp Lys Cys
C26H40N6O5S (548.2780750000001)
Lys Cys Ile Trp
C26H40N6O5S (548.2780750000001)
Lys Cys Leu Trp
C26H40N6O5S (548.2780750000001)
Lys Cys Trp Ile
C26H40N6O5S (548.2780750000001)
Lys Cys Trp Leu
C26H40N6O5S (548.2780750000001)
Lys Asp Met Arg
C21H40N8O7S (548.2740530000001)
Lys Asp Arg Met
C21H40N8O7S (548.2740530000001)
Lys Asp Thr Trp
Lys Asp Trp Thr
Lys Glu Ser Trp
Lys Glu Trp Ser
Lys His His Gln
Lys His Gln His
Lys Ile Cys Trp
C26H40N6O5S (548.2780750000001)
Lys Ile Trp Cys
C26H40N6O5S (548.2780750000001)
Lys Leu Cys Trp
C26H40N6O5S (548.2780750000001)
Lys Leu Trp Cys
C26H40N6O5S (548.2780750000001)
Lys Met Asp Arg
C21H40N8O7S (548.2740530000001)
Lys Met Arg Asp
C21H40N8O7S (548.2740530000001)
Lys Gln His His
Lys Arg Asp Met
C21H40N8O7S (548.2740530000001)
Lys Arg Met Asp
C21H40N8O7S (548.2740530000001)
Lys Ser Glu Trp
Lys Ser Trp Glu
Lys Thr Asp Trp
Lys Thr Trp Asp
Lys Trp Cys Ile
C26H40N6O5S (548.2780750000001)
Lys Trp Cys Leu
C26H40N6O5S (548.2780750000001)
Lys Trp Asp Thr
Lys Trp Glu Ser
Lys Trp Ile Cys
C26H40N6O5S (548.2780750000001)
Lys Trp Leu Cys
C26H40N6O5S (548.2780750000001)
Lys Trp Ser Glu
Lys Trp Thr Asp
Leu Cys Lys Trp
C26H40N6O5S (548.2780750000001)
Leu Cys Trp Lys
C26H40N6O5S (548.2780750000001)
Leu Lys Cys Trp
C26H40N6O5S (548.2780750000001)
Leu Lys Trp Cys
C26H40N6O5S (548.2780750000001)
Leu Trp Cys Lys
C26H40N6O5S (548.2780750000001)
Leu Trp Lys Cys
C26H40N6O5S (548.2780750000001)
Met Asp Lys Arg
C21H40N8O7S (548.2740530000001)
Met Asp Arg Lys
C21H40N8O7S (548.2740530000001)
Met Lys Asp Arg
C21H40N8O7S (548.2740530000001)
Met Lys Arg Asp
C21H40N8O7S (548.2740530000001)
Met Arg Asp Lys
C21H40N8O7S (548.2740530000001)
Met Arg Lys Asp
C21H40N8O7S (548.2740530000001)
Met Arg Arg Ser
Met Arg Ser Arg
Met Ser Arg Arg
Asn Pro Arg Tyr
Asn Pro Tyr Arg
Asn Arg Pro Tyr
Asn Arg Tyr Pro
Asn Tyr Pro Arg
Asn Tyr Arg Pro
Pro Asn Arg Tyr
Pro Asn Tyr Arg
Pro Arg Asn Tyr
Pro Arg Tyr Asn
Pro Tyr Asn Arg
Pro Tyr Arg Asn
Gln His His Lys
Gln His Lys His
Gln Lys His His
Arg Asp Lys Met
C21H40N8O7S (548.2740530000001)
Arg Asp Met Lys
C21H40N8O7S (548.2740530000001)
Arg Lys Asp Met
C21H40N8O7S (548.2740530000001)
Arg Lys Met Asp
C21H40N8O7S (548.2740530000001)
Arg Met Asp Lys
C21H40N8O7S (548.2740530000001)
Arg Met Lys Asp
C21H40N8O7S (548.2740530000001)
Arg Met Arg Ser
Arg Met Ser Arg
Arg Asn Pro Tyr
Arg Asn Tyr Pro
Arg Pro Asn Tyr
Arg Pro Tyr Asn
Arg Arg Met Ser
Arg Arg Ser Met
Arg Ser Met Arg
Arg Ser Arg Met
Arg Ser Thr Trp
Arg Ser Trp Thr
Arg Thr Ser Trp
Arg Thr Trp Ser
Arg Trp Ser Thr
Arg Trp Thr Ser
Arg Tyr Asn Pro
Arg Tyr Pro Asn
Ser Glu Lys Trp
Ser Glu Trp Lys
Ser Lys Glu Trp
Ser Lys Trp Glu
Ser Met Arg Arg
Ser Arg Met Arg
Ser Arg Arg Met
Ser Arg Thr Trp
Ser Arg Trp Thr
Ser Thr Arg Trp
Ser Thr Trp Arg
Ser Trp Glu Lys
Ser Trp Lys Glu
Ser Trp Arg Thr
Ser Trp Thr Arg
Thr Asp Lys Trp
Thr Asp Trp Lys
Thr Lys Asp Trp
Thr Lys Trp Asp
Thr Arg Ser Trp
Thr Arg Trp Ser
Thr Ser Arg Trp
Thr Ser Trp Arg
Thr Trp Asp Lys
Thr Trp Lys Asp
Thr Trp Arg Ser
Thr Trp Ser Arg
Val Phe Phe His
Val Phe His Phe
Val His Phe Phe
Trp Cys Ile Lys
C26H40N6O5S (548.2780750000001)
Trp Cys Lys Ile
C26H40N6O5S (548.2780750000001)
Trp Cys Lys Leu
C26H40N6O5S (548.2780750000001)
Trp Cys Leu Lys
C26H40N6O5S (548.2780750000001)
Trp Asp Lys Thr
Trp Asp Thr Lys
Trp Glu Lys Ser
Trp Glu Ser Lys
Trp Ile Cys Lys
C26H40N6O5S (548.2780750000001)
Trp Ile Lys Cys
C26H40N6O5S (548.2780750000001)
Trp Lys Cys Ile
C26H40N6O5S (548.2780750000001)
Trp Lys Cys Leu
C26H40N6O5S (548.2780750000001)
Trp Lys Asp Thr
Trp Lys Ile Cys
C26H40N6O5S (548.2780750000001)
Trp Lys Leu Cys
C26H40N6O5S (548.2780750000001)
Trp Leu Cys Lys
C26H40N6O5S (548.2780750000001)
Trp Leu Lys Cys
C26H40N6O5S (548.2780750000001)
Trp Arg Ser Thr
Trp Arg Thr Ser
Trp Ser Arg Thr
Trp Ser Thr Arg
Trp Thr Arg Ser
Trp Thr Ser Arg
Tyr Asn Pro Arg
Tyr Asn Arg Pro
Tyr Pro Asn Arg
Tyr Pro Arg Asn
Tyr Arg Asn Pro
Tyr Arg Pro Asn
peruvoside
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides C - Cardiovascular system > C01 - Cardiac therapy > C01A - Cardiac glycosides D002317 - Cardiovascular Agents
PKOHA-PA
C26H45O10P (548.2750199999999)
belfosdil
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates C93038 - Cation Channel Blocker
2-hydroxypropyl 2-methylprop-2-enoate,2-methylidenehexanoic acid,methyl 2-methylprop-2-enoate,prop-2-enoic acid,styrene
butyl prop-2-enoate,2-hydroxyethyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate,2-methylprop-2-enoic acid,styrene
o,o-bis(4-tert-butylbenzoyl)-n,n-diallyl-l-tartardiamide
Murabutide
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D007155 - Immunologic Factors
Imazamethabenz
Herbicidal metabolite of imazamethabenz-methyl. Acetolactate synthase inhibitor
[(1R,3S,4R,4aR,5S,7R,8S,8aR)-8-[(3aS,5S,6aS)-3a,4,5,6a-tetrahydrofuro[2,3-b]furan-5-yl]-5-acetyloxy-4a-(acetyloxymethyl)-3-hydroxy-7,8-dimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-1-yl] (E)-2-methylbut-2-enoate
Citrinin
Citrinin is practically insoluble (in water) and an extremely strong acidic compound (based on its pKa). Citrinin can be found in barley and common wheat, which makes citrinin a potential biomarker for the consumption of these food products. Citrinin is a mycotoxin which is often found in food. It is a secondary metabolite produced by fungi that contaminate long-stored food and it causes different toxic effects, like nephrotoxic, hepatotoxic and cytotoxic effects. Citrinin is mainly found in stored grains, but sometimes also in fruits and other plant products .
3-(3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl)oxy-14-hydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-10-carbaldehyde
Tamoxifen-N-glucuronide
Tamoxifen-N-glucuronide is a metabolite of tamoxifen. Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen. In other tissues such as the endometrium, it behaves as an agonist, and thus may be characterized as a mixed agonist/antagonist. Tamoxifen is the usual endocrine therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting. (Wikipedia)
[(2R,6S,7R,8R)-3-[(3-formamido-2-hydroxybenzoyl)amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl] 3-methylbutanoate
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D000935 - Antifungal Agents
3-[(21S,22S)-16-ethenyl-11,26-diethyl-4-hydroxy-12,17,21-trimethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid
Butyl 2-[2-[2-(2-acetamido-4,5,6-trihydroxy-1-oxohexan-3-yl)oxypropanoylamino]propanoylamino]-5-amino-5-oxopentanoate
3-methylbutanoic acid [(2R,6S,7R,8R)-3-[[(3-formamido-2-hydroxyphenyl)-oxomethyl]amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl] ester
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D000935 - Antifungal Agents
(3S,6S,7R,8aR)-6-[3-(2-hydroxyethoxy)phenyl]-N-[5-[(2-mercapto-1-oxoethyl)amino]pentyl]-3-(2-methylpropyl)-1,4-dioxo-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-7-carboxamide
1-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-[4-(trifluoromethyl)phenyl]urea
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[(5-phenyl-3-isoxazolyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
1-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-[4-(trifluoromethyl)phenyl]urea
1-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-[4-(trifluoromethyl)phenyl]urea
1-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-[4-(trifluoromethyl)phenyl]urea
[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
C26H45O10P (548.2750199999999)
[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
C26H45O10P (548.2750199999999)
[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
C26H45O10P (548.2750199999999)
[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
C26H45O10P (548.2750199999999)
2,3-bis(acetyloxy)-4,14,15,15-tetramethyl-8-methylidene-13-oxotetracyclo[9.3.1.0¹,⁹.0⁴,⁹]pentadecan-7-yl 3-phenylprop-2-enoate
(6s)-6-[(1s,3ar,4s,7s,9as,11s,11ar)-4,7,11-trihydroxy-3a,6,6,9a,11a-pentamethyl-3,10-dioxo-1h,2h,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-4-oxoheptanoic acid
8-(3,4-dihydroxybenzoyl)-10-(3,7-dimethylocta-2,6-dien-1-yl)-5,5-dimethyl-10-(3-methylbut-2-en-1-yl)-2,6-dioxatricyclo[5.4.0.0¹,³]undec-7-ene-9,11-dione
(2r,3'r,4'ar,5's,6'r,6'ar,10'ar,10'br)-5'-(acetyloxy)-6'a-[(acetyloxy)methyl]-4'a,10'b-dimethyl-5''-oxo-octahydrodispiro[oxirane-2,7'-naphtho[2,1-b]pyran-3',3''-oxolan]-6'-yl (2e)-2-methylbut-2-enoate
n-[2,6-dimethyl-8-(3-methylbutyl)-7-[(4-methylpentanoyl)oxy]-4,9-dioxo-1,5-dioxonan-3-yl]-2-hydroxy-3-[(hydroxymethylidene)amino]benzenecarboximidic acid
n-{7-hexyl-4,9-dimethyl-8-[(3-methylbutanoyl)oxy]-2,6-dioxo-1,5-dioxonan-3-yl}-2-hydroxy-3-[(hydroxymethylidene)amino]benzenecarboximidic acid
{[(4e,8s,9s,10e,12s,13r,14s,16r)-3,13,22-trihydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-19,20-dioxo-2-azabicyclo[16.3.1]docosa-1(21),2,4,10,18(22)-pentaen-9-yl]oxy}methanimidic acid
({10,11,15-trihydroxy-6,21-dimethoxy-2,4,10,19-tetramethyl-8-oxo-22-oxa-12-azatricyclo[11.8.2.0¹⁷,²³]tricosa-3,11,13,15,17(23)-pentaen-5-yl}oxy)methanimidic acid
(1r,2r,3bs,9br,11ar)-1-acetyl-2,7-dihydroxy-3a,6,9b,11a-tetramethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,5h,11h-cyclopenta[a]phenanthren-10-one
4-[(1r,3s,5s,7s,10s,11r,14r,15r,18r)-7-{[(2r,3r,4r,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-18-hydroxy-10,14-dimethyl-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadecan-15-yl]-5h-furan-2-one
(1s,3r,5s,7r,9r,10s,12r,14r,15s,18r,19r,20r,22s,23r)-9,10,20,22-tetrahydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde
4-[(1s,2s,4r,5s,6s,9s,10r,13r,15s,18s)-15-{[(2r,3r,4r,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-9-hydroxy-5,18-dimethyl-3-oxapentacyclo[8.8.0.0²,⁴.0⁵,⁹.0¹³,¹⁸]octadecan-6-yl]-5h-furan-2-one
n-[(3s,4r,7r,8r,9s)-7-hexyl-4,9-dimethyl-8-{[(2s)-2-methylbutanoyl]oxy}-2,6-dioxo-1,5-dioxonan-3-yl]-2-hydroxy-3-[(hydroxymethylidene)amino]benzenecarboximidic acid
(1r,3r,5r,6ar,7r,8r,9s,10s,10ar)-1-(acetyloxy)-9-(butanoyloxy)-5,10-dihydroxy-7,8-dimethyl-7-[(2z)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-3-yl butanoate
5-[(1r,3as,3br,5ar,7s,9as,9bs,10r,11ar)-3a,10-dihydroxy-9a,11a-dimethyl-7-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-tetradecahydrocyclopenta[a]phenanthren-1-yl]pyran-2-one
(1'r,2r,2's,4'r,5's,6'r,7's,8's,11'r)-5'-[(2s,3ar,6as)-hexahydrofuro[2,3-b]furan-2-yl]-2',11'-bis(acetyloxy)-4',5'-dimethyl-12'-oxaspiro[oxirane-2,10'-tricyclo[6.2.2.0¹,⁶]dodecan]-7'-yl (2e)-2-methylbut-2-enoate
anticancer cardiacglycoside pmv70p691-007
{"Ingredient_id": "HBIN016314","Ingredient_name": "anticancer cardiacglycoside pmv70p691-007","Alias": "NA","Ingredient_formula": "C30H44O9","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1389","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
anticancer cardiacglycoside pmv70p691-008
{"Ingredient_id": "HBIN016315","Ingredient_name": "anticancer cardiacglycoside pmv70p691-008","Alias": "NA","Ingredient_formula": "C30H44O9","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1390","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}